应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVCT Nuvectis Pharma, Inc.
未开盘 02-11 16:00:00 EST
8.78
+0.04
+0.46%
盘后
8.78
+0.00
0.00%
19:03 EST
最高
8.85
最低
8.12
成交量
10.50万
今开
8.85
昨收
8.74
日振幅
8.35%
总市值
2.25亿
流通市值
1.28亿
总股本
2,561万
成交额
88.95万
换手率
0.72%
流通股本
1,454万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Nuvectis Pharma 宣布启动 Nxp900 与 Osimertinib 联合治疗非小细胞肺癌的 1B 相研究
美股速递 · 2025-12-17
Nuvectis Pharma 宣布启动 Nxp900 与 Osimertinib 联合治疗非小细胞肺癌的 1B 相研究
Nuvectis Pharma, Inc.盘中异动 股价大涨5.27%
市场透视 · 2025-03-10
Nuvectis Pharma, Inc.盘中异动 股价大涨5.27%
Nuvectis Pharma, Inc.盘中异动 早盘股价大涨5.05%报6.45美元
市场透视 · 2025-03-04
Nuvectis Pharma, Inc.盘中异动 早盘股价大涨5.05%报6.45美元
Nuvectis Pharma, Inc.盘中异动 早盘快速跳水5.01%
市场透视 · 2025-03-03
Nuvectis Pharma, Inc.盘中异动 早盘快速跳水5.01%
Nuvectis Pharma, Inc.2024财年实现净利润-19.00百万美元,同比增加14.65%
市场透视 · 2025-03-02
Nuvectis Pharma, Inc.2024财年实现净利润-19.00百万美元,同比增加14.65%
Nuvectis Pharma, Inc.盘中异动 早盘急速上涨6.21%报7.36美元
市场透视 · 2025-02-26
Nuvectis Pharma, Inc.盘中异动 早盘急速上涨6.21%报7.36美元
HC Wainwright & Co.:维持Nuvectis Pharma(NVCT.US)评级,由买入调整至买入评级, 目标价由21.00美元调整至11.00美元。
金融界 · 2025-02-26
HC Wainwright & Co.:维持Nuvectis Pharma(NVCT.US)评级,由买入调整至买入评级, 目标价由21.00美元调整至11.00美元。
Nuvectis Pharma, Inc.盘中异动 临近午盘急速下挫5.03%报6.99美元
市场透视 · 2025-02-26
Nuvectis Pharma, Inc.盘中异动 临近午盘急速下挫5.03%报6.99美元
Nuvectis Pharma, Inc.盘中异动 大幅拉升5.76%报7.35美元
市场透视 · 2025-02-15
Nuvectis Pharma, Inc.盘中异动 大幅拉升5.76%报7.35美元
Nuvectis Pharma, Inc.盘中异动 股价大跌5.37%报6.35美元
市场透视 · 2025-02-10
Nuvectis Pharma, Inc.盘中异动 股价大跌5.37%报6.35美元
Nuvectis Pharma, Inc.盘中异动 急速跳水6.75%
市场透视 · 2025-02-08
Nuvectis Pharma, Inc.盘中异动 急速跳水6.75%
Nuvectis Pharma, Inc.盘中异动 早盘快速上涨5.74%报7.19美元
市场透视 · 2025-02-04
Nuvectis Pharma, Inc.盘中异动 早盘快速上涨5.74%报7.19美元
Nuvectis Pharma, Inc.盘中异动 早盘快速下挫5.03%
市场透视 · 2025-02-03
Nuvectis Pharma, Inc.盘中异动 早盘快速下挫5.03%
Nuvectis Pharma, Inc.盘中异动 股价大涨5.81%
市场透视 · 2025-01-31
Nuvectis Pharma, Inc.盘中异动 股价大涨5.81%
Nuvectis Pharma, Inc.盘中异动 股价大涨5.45%报6.77美元
市场透视 · 2025-01-25
Nuvectis Pharma, Inc.盘中异动 股价大涨5.45%报6.77美元
Nuvectis Pharma, Inc.盘中异动 临近收盘股价大涨5.08%
市场透视 · 2025-01-23
Nuvectis Pharma, Inc.盘中异动 临近收盘股价大涨5.08%
Nuvectis Pharma, Inc.盘中异动 下午盘大幅下跌6.11%
市场透视 · 2025-01-15
Nuvectis Pharma, Inc.盘中异动 下午盘大幅下跌6.11%
Nuvectis Pharma, Inc.盘中异动 股价大跌5.85%
市场透视 · 2025-01-13
Nuvectis Pharma, Inc.盘中异动 股价大跌5.85%
Nuvectis Pharma, Inc.盘中异动 股价大跌5.02%报5.86美元
市场透视 · 2025-01-10
Nuvectis Pharma, Inc.盘中异动 股价大跌5.02%报5.86美元
Nuvectis Pharma, Inc.盘中异动 早盘大幅跳水5.30%
市场透视 · 2025-01-08
Nuvectis Pharma, Inc.盘中异动 早盘大幅跳水5.30%
暂无数据
公司概况
公司名称:
Nuvectis Pharma, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nuvectis Pharma, Inc.于2020年7月27日根据特拉华州法律注册成立。该公司是一家生物制药公司,专注于开发用于治疗严重未满足的肿瘤医疗需求的创新精准药物。公司的发展战略采用基于精准医学的方法,将与致癌驱动因素、通路成瘾和其促癌因素相关的关键科学见解转化为选择性、强效和高选择性的抗癌药物。该公司相信,这些进步为靶向疗法的现代发展奠定了基础,这将使基于肿瘤基因特征而非肿瘤组织学的抗癌疗法的发现和开发成为可能。
发行价格:
--
{"stockData":{"symbol":"NVCT","market":"US","secType":"STK","nameCN":"Nuvectis Pharma, Inc.","latestPrice":8.78,"timestamp":1770843600000,"preClose":8.74,"halted":0,"volume":105002,"hourTrading":{"tag":"盘后","latestPrice":8.78,"preClose":8.78,"latestTime":"19:03 EST","volume":3046,"amount":26745.2,"timestamp":1770854627174,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.004576659038901504,"floatShares":14536600,"shares":25614896,"eps":-1.359454,"marketStatus":"未开盘","change":0.04,"latestTime":"02-11 16:00:00 EST","open":8.85,"high":8.85,"low":8.12,"amount":889455.3516839999,"amplitude":0.083524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.359454,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770886800000},"marketStatusCode":0,"adr":0,"listingDate":1638334800000,"exchange":"NASDAQ","adjPreClose":8.74,"postHourTrading":{"tag":"盘后","latestPrice":8.78,"preClose":8.78,"latestTime":"19:03 EST","volume":3046,"amount":26745.2,"timestamp":1770854627174,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.472249,"impliedVol":1.1683,"impliedVolPercentile":0.4622},"requestUrl":"/m/hq/s/NVCT/tweets","defaultTab":"tweets","newsList":[{"id":"1193391794","title":"Nuvectis Pharma 宣布启动 Nxp900 与 Osimertinib 联合治疗非小细胞肺癌的 1B 相研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1193391794","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193391794?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:03","pubTimestamp":1765972988,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma 宣布启动 Nxp900 与 Osimertinib 联合治疗非小细胞肺癌的 1B 相研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2518222695","title":"Nuvectis Pharma, Inc.盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222695?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:43","pubTimestamp":1741614229,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时43分,Nuvectis Pharma, Inc.股票出现异动,股价急速上涨5.27%。截至发稿,该股报7.30美元/股,成交量2.9377万股,换手率0.13%,振幅5.48%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。其相关个股中,Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2382.81%、559.93%、84.17%,振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.,振幅分别为40.24%、28.59%、25.35%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214349a26a295e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214349a26a295e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2516677943","title":"Nuvectis Pharma, Inc.盘中异动 早盘股价大涨5.05%报6.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677943?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:43","pubTimestamp":1741099391,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时43分,Nuvectis Pharma, Inc.股票出现波动,股价快速上涨5.05%。截至发稿,该股报6.45美元/股,成交量4611股,换手率0.02%,振幅5.37%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为1120.39%、1104.72%、461.59%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为37.67%、22.25%、21.85%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422431196394834&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422431196394834&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2516580866","title":"Nuvectis Pharma, Inc.盘中异动 早盘快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516580866?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:59","pubTimestamp":1741017564,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时59分,Nuvectis Pharma, Inc.股票出现波动,股价大幅跳水5.01%。截至发稿,该股报6.36美元/股,成交量3.0621万股,换手率0.13%,振幅5.98%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.51%。其相关个股中,Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大,Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为3027.60%、142.96%、134.56%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.,振幅分别为206.20%、70.53%、50.09%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235924989a2605&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235924989a2605&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2516552208","title":"Nuvectis Pharma, Inc.2024财年实现净利润-19.00百万美元,同比增加14.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516552208?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:01","pubTimestamp":1740844860,"startTime":"0","endTime":"0","summary":"3月2日,Nuvectis Pharma, Inc.公布财报,公告显示公司2024财年净利润为-19.00百万美元,同比增加14.65%;其中营业收入为0.00美元,每股基本收益为-1.11美元。从资产负债表来看,Nuvectis Pharma, Inc.总负债8.89百万美元,其中短期债务0.00美元,资产负债比为2.10,流动比率为2.10。机构评级:截至2025年3月2日,当前有3家机构对Nuvectis Pharma, Inc.目标价做出预测,其中目标均价为16.33美元,其中最低目标价为11.00美元,最高目标价为20.00美元。其产品线包括NXP800、NXP900。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000118abe2c59a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000118abe2c59a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT"],"gpt_icon":0},{"id":"2514856197","title":"Nuvectis Pharma, Inc.盘中异动 早盘急速上涨6.21%报7.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856197?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:35","pubTimestamp":1740580504,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时35分,Nuvectis Pharma, Inc.股票出现异动,股价快速拉升6.21%。截至发稿,该股报7.36美元/股,成交量2350股,换手率0.01%,振幅0.00%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Channel Therapeutics Corporation、Immunoprecise Antibodies Ltd.涨幅较大,Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为127.52%、95.24%、76.83%,振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nutriband Inc C/Wts 、Channel Therapeutics Corporation,振幅分别为38.41%、17.13%、16.86%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223505a254f771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223505a254f771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2514014642","title":"HC Wainwright & Co.:维持Nuvectis Pharma(NVCT.US)评级,由买入调整至买入评级, 目标价由21.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514014642","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514014642?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:52","pubTimestamp":1740502323,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Nuvectis Pharma(NVCT.US)评级,由买入调整至买入评级, 目标价由21.00美元调整至11.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26005248385931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NVCT"],"gpt_icon":0},{"id":"2514012679","title":"Nuvectis Pharma, Inc.盘中异动 临近午盘急速下挫5.03%报6.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514012679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514012679?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:44","pubTimestamp":1740501845,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时44分,Nuvectis Pharma, Inc.股票出现异动,股价快速下挫5.03%。截至发稿,该股报6.99美元/股,成交量4.2608万股,换手率0.19%,振幅4.76%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。其相关个股中,Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大,Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为1464.35%、1120.54%、931.53%,振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ,振幅分别为241.19%、87.83%、66.67%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260044069892680c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260044069892680c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2511137316","title":"Nuvectis Pharma, Inc.盘中异动 大幅拉升5.76%报7.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511137316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511137316?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:12","pubTimestamp":1739553159,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时12分,Nuvectis Pharma, Inc.股票出现异动,股价快速拉升5.76%。截至发稿,该股报7.35美元/股,成交量9.1569万股,换手率0.41%,振幅5.47%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.48%。其相关个股中,Moleculin Biotech, Inc.、Allogene Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为2869.01%、749.19%、581.98%,振幅较大的相关个股有Moleculin Biotech, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Abpro Holdings Inc C/Wts 12/11/2029 ,振幅分别为71.65%、70.63%、66.45%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215011239abcf28e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215011239abcf28e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2510866686","title":"Nuvectis Pharma, Inc.盘中异动 股价大跌5.37%报6.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510866686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510866686?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:59","pubTimestamp":1739199546,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时59分,Nuvectis Pharma, Inc.股票出现异动,股价急速下挫5.37%。截至发稿,该股报6.35美元/股,成交量9325股,换手率0.04%,振幅6.41%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃,换手率分别为2265.08%、1425.61%、840.03%,振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为59.71%、51.99%、39.57%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225906a240a889&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225906a240a889&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2509729928","title":"Nuvectis Pharma, Inc.盘中异动 急速跳水6.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509729928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509729928?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:55","pubTimestamp":1738947337,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时55分,Nuvectis Pharma, Inc.股票出现波动,股价大幅跳水6.75%。截至发稿,该股报6.75美元/股,成交量8.3906万股,换手率0.37%,振幅5.52%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.55%。其相关个股中,Conduit Pharmaceuticals Inc.、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃,换手率分别为5370.19%、168.67%、102.86%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为130.43%、67.10%、53.38%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208005538987dc724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208005538987dc724&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2508745745","title":"Nuvectis Pharma, Inc.盘中异动 早盘快速上涨5.74%报7.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508745745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508745745?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:37","pubTimestamp":1738679878,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时37分,Nuvectis Pharma, Inc.股票出现波动,股价快速上涨5.74%。截至发稿,该股报7.19美元/股,成交量5745股,换手率0.03%,振幅3.82%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大,Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃,换手率分别为1053.56%、727.07%、191.65%,振幅较大的相关个股有Azitra Inc、Invivyd, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为38.71%、21.70%、21.03%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223759a2392a20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223759a2392a20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2508396144","title":"Nuvectis Pharma, Inc.盘中异动 早盘快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508396144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508396144?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:00","pubTimestamp":1738594851,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时00分,Nuvectis Pharma, Inc.股票出现异动,股价大幅下挫5.03%。截至发稿,该股报6.42美元/股,成交量6351股,换手率0.03%,振幅2.59%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.62%。其相关个股中,Gh Research Plc、Invivyd, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Cyclerion Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.、Hepion Pharmaceuticals, Inc.较为活跃,换手率分别为245.73%、81.27%、36.01%,振幅较大的相关个股有Invivyd, Inc.、Seastar Medical Holding Corporation、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为64.33%、33.48%、33.33%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323005298797406&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323005298797406&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2507297608","title":"Nuvectis Pharma, Inc.盘中异动 股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507297608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507297608?lang=zh_cn&edition=full","pubTime":"2025-01-31 05:01","pubTimestamp":1738270902,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日05时01分,Nuvectis Pharma, Inc.股票出现波动,股价急速上涨5.81%。截至发稿,该股报6.74美元/股,成交量2.9868万股,换手率0.15%,振幅5.29%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Tectonic Therapeutic, Inc.、Dominari Holdings Inc.、Alterity Therapeutics Limited涨幅较大,Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃,换手率分别为1850.62%、350.99%、260.67%,振幅较大的相关个股有Dominari Holdings Inc.、Cero Therapeutics Holdings, Inc.、Kazia Therapeutics Limited,振幅分别为70.55%、65.98%、65.94%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013105014396146823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013105014396146823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2506898647","title":"Nuvectis Pharma, Inc.盘中异动 股价大涨5.45%报6.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506898647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506898647?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:33","pubTimestamp":1737736422,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时33分,Nuvectis Pharma, Inc.股票出现波动,股价急速拉升5.45%。截至发稿,该股报6.77美元/股,成交量2.5871万股,换手率0.13%,振幅6.39%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.18%。其相关个股中,Evaxion Biotech As、Pmgc Holdings Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大,Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为3904.75%、2130.68%、1580.37%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Windtree Therapeutics, Inc.,振幅分别为134.08%、112.09%、66.25%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125003342a22e74c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125003342a22e74c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2505706878","title":"Nuvectis Pharma, Inc.盘中异动 临近收盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505706878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505706878?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:54","pubTimestamp":1737579273,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时54分,Nuvectis Pharma, Inc.股票出现异动,股价快速拉升5.08%。截至发稿,该股报6.00美元/股,成交量3.2505万股,换手率0.17%,振幅5.60%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.55%。其相关个股中,Nutriband Inc C/Wts 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Nutriband Inc.涨幅较大,Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为1046.40%、482.16%、106.84%,振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Immunoprecise Antibodies Ltd.、Eterna Therapeutics Inc.,振幅分别为68.99%、63.37%、63.32%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123045433960d3a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123045433960d3a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2503919686","title":"Nuvectis Pharma, Inc.盘中异动 下午盘大幅下跌6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503919686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503919686?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:02","pubTimestamp":1736884971,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时02分,Nuvectis Pharma, Inc.股票出现波动,股价快速下跌6.11%。截至发稿,该股报5.46美元/股,成交量2.5444万股,换手率0.13%,振幅6.71%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为1.12%。其相关个股中,Eterna Therapeutics Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大,Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃,换手率分别为1081.94%、601.34%、421.46%,振幅较大的相关个股有Eterna Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.,振幅分别为170.74%、146.24%、69.81%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115040251a221fd31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115040251a221fd31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2503658695","title":"Nuvectis Pharma, Inc.盘中异动 股价大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503658695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503658695?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:58","pubTimestamp":1736780288,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时58分,Nuvectis Pharma, Inc.股票出现异动,股价大幅下挫5.85%。截至发稿,该股报5.47美元/股,成交量9255股,换手率0.05%,振幅7.03%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为1.32%。其相关个股中,Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为5536.25%、3272.99%、407.04%,振幅较大的相关个股有Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.,振幅分别为124.54%、104.79%、102.37%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132258089864daef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132258089864daef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2502898806","title":"Nuvectis Pharma, Inc.盘中异动 股价大跌5.02%报5.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502898806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502898806?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:10","pubTimestamp":1736521858,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时10分,Nuvectis Pharma, Inc.股票出现异动,股价快速跳水5.02%。截至发稿,该股报5.86美元/股,成交量1.3536万股,换手率0.07%,振幅6.26%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为1.34%。其相关个股中,Conduit Pharmaceuticals Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Precision Biosciences, Inc.涨幅较大,Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃,换手率分别为1099.65%、392.71%、199.14%,振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.,振幅分别为85.00%、41.78%、37.29%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231059aba60d05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231059aba60d05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2501717007","title":"Nuvectis Pharma, Inc.盘中异动 早盘大幅跳水5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501717007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501717007?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:49","pubTimestamp":1736347767,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时49分,Nuvectis Pharma, Inc.股票出现波动,股价大幅跳水5.30%。截至发稿,该股报5.90美元/股,成交量1.1002万股,换手率0.06%,振幅6.22%。Nuvectis Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大,Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为1825.63%、543.59%、516.06%,振幅较大的相关个股有Silo Pharma, Inc.、Sana Biotechnology, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为135.78%、109.09%、68.53%。Nuvectis Pharma, Inc.公司简介:Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108224927985f7bde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108224927985f7bde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nuvectis.com","stockEarnings":[{"period":"1week","weight":0.0307},{"period":"1month","weight":0.0331},{"period":"3month","weight":0.4542},{"period":"6month","weight":0.3593},{"period":"1year","weight":0.3807},{"period":"ytd","weight":0.1576}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nuvectis Pharma, Inc.于2020年7月27日根据特拉华州法律注册成立。该公司是一家生物制药公司,专注于开发用于治疗严重未满足的肿瘤医疗需求的创新精准药物。公司的发展战略采用基于精准医学的方法,将与致癌驱动因素、通路成瘾和其促癌因素相关的关键科学见解转化为选择性、强效和高选择性的抗癌药物。该公司相信,这些进步为靶向疗法的现代发展奠定了基础,这将使基于肿瘤基因特征而非肿瘤组织学的抗癌疗法的发现和开发成为可能。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.130119},{"month":2,"riseRate":0.75,"avgChangeRate":0.143364},{"month":3,"riseRate":0.75,"avgChangeRate":0.129194},{"month":4,"riseRate":0.75,"avgChangeRate":0.042967},{"month":5,"riseRate":0.75,"avgChangeRate":0.205701},{"month":6,"riseRate":0,"avgChangeRate":-0.153353},{"month":7,"riseRate":0.25,"avgChangeRate":-0.099906},{"month":8,"riseRate":0.5,"avgChangeRate":-0.005612},{"month":9,"riseRate":0,"avgChangeRate":-0.100626},{"month":10,"riseRate":0.5,"avgChangeRate":-0.011793},{"month":11,"riseRate":0.25,"avgChangeRate":-0.090389},{"month":12,"riseRate":0.75,"avgChangeRate":0.071233}],"exchange":"NASDAQ","name":"Nuvectis Pharma, Inc.","nameEN":"Nuvectis Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvectis Pharma, Inc.(NVCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nuvectis Pharma, Inc.(NVCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nuvectis Pharma, Inc.,NVCT,Nuvectis Pharma, Inc.股票,Nuvectis Pharma, Inc.股票老虎,Nuvectis Pharma, Inc.股票老虎国际,Nuvectis Pharma, Inc.行情,Nuvectis Pharma, Inc.股票行情,Nuvectis Pharma, Inc.股价,Nuvectis Pharma, Inc.股市,Nuvectis Pharma, Inc.股票价格,Nuvectis Pharma, Inc.股票交易,Nuvectis Pharma, Inc.股票购买,Nuvectis Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvectis Pharma, Inc.(NVCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nuvectis Pharma, Inc.(NVCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}